Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment-Reference-Cited by-同舟云学术

Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment

Published:2017-07-14 Issue: Volume: Page:bcr-2016-218514
ISSN:1757-790X
Container-title:BMJ Case Reports
language:en
Short-container-title:BMJ Case Reports

Author:

Tanios Georges,Mungo Nicolas Andrews,Kapila Aaysha,Bajaj Kailash

Publisher

BMJ

Subject

General Medicine

Reference30 articles.

1. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists;Sinnadurai;J Clin Neurosci,2010

2. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer;Guerra;Pituitary,2010

3. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature;Hands;Endocr Pract,2007

4. Pituitary apoplexy after leuprolide;Davis;Pituitary,2006

5. Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration;Hernandez Morin;Ann Endocrinol,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary Apoplexy After Leuprolide Therapy in a Breast Cancer Patient: A Case Report;Brain Tumor Research and Treatment;2023

2. The presenting visual symptoms of optic chiasmal disease;European Journal of Ophthalmology;2022-09-22

3. Role of leuprorelin on ovarian function of patients with receptor-positive premenopausal breast cancer;PAK J PHARM SCI;2021

4. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review;Journal of Cancer Research and Clinical Oncology;2021-06-22

5. GnRH agonist-associated pituitary apoplexy: a case series and review of the literature;Pituitary;2021-04-09